| Autor: |
Tolić Ena, Basara, Latinka, Janković Makek, Mateja, Hećimović, Ana, Butorac-Petanjek, Bojana, Jalušić Glunčić, Tajana, Muršić, Davorka, Boras, Zagorka, Darapi, Dora, Doder, Filip, Radić, Višnja, Vukić Dugac, Andrea, Pavliša, Gordana, Samaržija Miroslav |
| Jazyk: |
angličtina |
| Rok vydání: |
2022 |
| Předmět: |
|
| Popis: |
AIM While most patients with acute COVID-19 infection experience full recovery, a number of patients with COVID-19 pneumonia experience long- term lung function disorders. In this study, we aimed to evaluate pulmonary function tests of COVID-19 survivors. METHODS The study included 125 COVID-19 survivors without previous chronic lung disease, who were referred to the Clinic for Respiratory Diseases Jordanovac in the period between November 2020 and April 2021. We categorized them into two groups according to the Croatian Institute of Public Health's criteria: mild/moderate and severe/critical acute COVID-19 disease. Each group was then divided into two subgroups – patients examined in the first three months (early recovery phase), and those examined in the period after six months following acute illness (late recovery phase). We analyzed the results of spirometry and the diffusing capacity of the lungs (DLCO). RESULTS There were 62 patients in the mild/moderate group, of which 30 were examined in the early phase, and 32 in the late phase of recovery. Out of 63 patients in the severe/critical group, 34 and 29 were evaluated in the early and late phase of recovery, respectively. Distribution according to sex and age was similar in all subgroups, with male predominance (72.5%) and a mean age of 56.3 ±11 years. In the early phase, 10% of patients with non-severe and 47% of patients with severe COVID- 19 demonstrated pulmonary diffusion impairment (DLCO |
| Databáze: |
OpenAIRE |
| Externí odkaz: |
|
